Venovenous extracorporeal membrane oxygenation in pediatric respiratory failure

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Conventional treatment of respiratory failure involves positive pressure ventilation that can worsen lung damage. Extracorporeal membrane oxygenation (ECMO) is typically used when conventional therapy fails. In this study, we evaluated the use of venovenous (VV)-ECMO for the treatment of severe pediatric respiratory failure at our institution. A retrospective analysis of pediatric patients (age 1-18) placed on ECMO in the last 15 years (1999-2014) by the pediatric surgery team for respiratory failure was performed. Five pediatric patients underwent ECMO (mean age 10 years; range, 2-16). All underwent VV-ECMO. Diagnoses were status asthmaticus (2), acute respiratory distress syndrome due to septic shock (1), aspergillus pneumonia (1), and respiratory failure due to parainfluenza (1). Two patients had severe barotrauma prior to ECMO initiation. Average oxygenation index (OI) prior to cannulation was 74 (range 23-122). No patients required conversion to VA-ECMO. The average ECMO run time was 4.4 days (range 2-6). The average number of days on the ventilator was 15 (range 4-27). There were no major complications due to the procedure. Survival to discharge was 100%. Average follow up is 4.4 years (range 1-15). A short run of VV-ECMO can be lifesaving for pediatric patients in respiratory failure. Survival is excellent despite severely elevated oxygen indices. VV-ECMO may be well tolerated and can be considered for severe pediatric respiratory failure.

Original languageEnglish (US)
Pages (from-to)787-788
Number of pages2
JournalAmerican Surgeon
Volume82
Issue number9
StatePublished - Sep 1 2016

Fingerprint

Extracorporeal Membrane Oxygenation
Respiratory Insufficiency
Pediatrics
Status Asthmaticus
Barotrauma
Paramyxoviridae Infections
Survival
Positive-Pressure Respiration
Adult Respiratory Distress Syndrome
Aspergillus
Mechanical Ventilators
Septic Shock
Treatment Failure
Catheterization
Pneumonia
Oxygen
Lung

ASJC Scopus subject areas

  • Surgery

Cite this

Venovenous extracorporeal membrane oxygenation in pediatric respiratory failure. / Ham, P. Benson; Hwang, Brice; Wise, Linda J.; Walters, K. Christian; Pipkin, Walter L.; Howell, Charles G.; Bhatia, Jatinder; Hatley, Robyn.

In: American Surgeon, Vol. 82, No. 9, 01.09.2016, p. 787-788.

Research output: Contribution to journalArticle

@article{b2dd45e6b41d47e59e3db070eb9c4366,
title = "Venovenous extracorporeal membrane oxygenation in pediatric respiratory failure",
abstract = "Conventional treatment of respiratory failure involves positive pressure ventilation that can worsen lung damage. Extracorporeal membrane oxygenation (ECMO) is typically used when conventional therapy fails. In this study, we evaluated the use of venovenous (VV)-ECMO for the treatment of severe pediatric respiratory failure at our institution. A retrospective analysis of pediatric patients (age 1-18) placed on ECMO in the last 15 years (1999-2014) by the pediatric surgery team for respiratory failure was performed. Five pediatric patients underwent ECMO (mean age 10 years; range, 2-16). All underwent VV-ECMO. Diagnoses were status asthmaticus (2), acute respiratory distress syndrome due to septic shock (1), aspergillus pneumonia (1), and respiratory failure due to parainfluenza (1). Two patients had severe barotrauma prior to ECMO initiation. Average oxygenation index (OI) prior to cannulation was 74 (range 23-122). No patients required conversion to VA-ECMO. The average ECMO run time was 4.4 days (range 2-6). The average number of days on the ventilator was 15 (range 4-27). There were no major complications due to the procedure. Survival to discharge was 100{\%}. Average follow up is 4.4 years (range 1-15). A short run of VV-ECMO can be lifesaving for pediatric patients in respiratory failure. Survival is excellent despite severely elevated oxygen indices. VV-ECMO may be well tolerated and can be considered for severe pediatric respiratory failure.",
author = "Ham, {P. Benson} and Brice Hwang and Wise, {Linda J.} and Walters, {K. Christian} and Pipkin, {Walter L.} and Howell, {Charles G.} and Jatinder Bhatia and Robyn Hatley",
year = "2016",
month = "9",
day = "1",
language = "English (US)",
volume = "82",
pages = "787--788",
journal = "Handbook of Behavioral Neuroscience",
issn = "0003-1348",
publisher = "JAI Press",
number = "9",

}

TY - JOUR

T1 - Venovenous extracorporeal membrane oxygenation in pediatric respiratory failure

AU - Ham, P. Benson

AU - Hwang, Brice

AU - Wise, Linda J.

AU - Walters, K. Christian

AU - Pipkin, Walter L.

AU - Howell, Charles G.

AU - Bhatia, Jatinder

AU - Hatley, Robyn

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Conventional treatment of respiratory failure involves positive pressure ventilation that can worsen lung damage. Extracorporeal membrane oxygenation (ECMO) is typically used when conventional therapy fails. In this study, we evaluated the use of venovenous (VV)-ECMO for the treatment of severe pediatric respiratory failure at our institution. A retrospective analysis of pediatric patients (age 1-18) placed on ECMO in the last 15 years (1999-2014) by the pediatric surgery team for respiratory failure was performed. Five pediatric patients underwent ECMO (mean age 10 years; range, 2-16). All underwent VV-ECMO. Diagnoses were status asthmaticus (2), acute respiratory distress syndrome due to septic shock (1), aspergillus pneumonia (1), and respiratory failure due to parainfluenza (1). Two patients had severe barotrauma prior to ECMO initiation. Average oxygenation index (OI) prior to cannulation was 74 (range 23-122). No patients required conversion to VA-ECMO. The average ECMO run time was 4.4 days (range 2-6). The average number of days on the ventilator was 15 (range 4-27). There were no major complications due to the procedure. Survival to discharge was 100%. Average follow up is 4.4 years (range 1-15). A short run of VV-ECMO can be lifesaving for pediatric patients in respiratory failure. Survival is excellent despite severely elevated oxygen indices. VV-ECMO may be well tolerated and can be considered for severe pediatric respiratory failure.

AB - Conventional treatment of respiratory failure involves positive pressure ventilation that can worsen lung damage. Extracorporeal membrane oxygenation (ECMO) is typically used when conventional therapy fails. In this study, we evaluated the use of venovenous (VV)-ECMO for the treatment of severe pediatric respiratory failure at our institution. A retrospective analysis of pediatric patients (age 1-18) placed on ECMO in the last 15 years (1999-2014) by the pediatric surgery team for respiratory failure was performed. Five pediatric patients underwent ECMO (mean age 10 years; range, 2-16). All underwent VV-ECMO. Diagnoses were status asthmaticus (2), acute respiratory distress syndrome due to septic shock (1), aspergillus pneumonia (1), and respiratory failure due to parainfluenza (1). Two patients had severe barotrauma prior to ECMO initiation. Average oxygenation index (OI) prior to cannulation was 74 (range 23-122). No patients required conversion to VA-ECMO. The average ECMO run time was 4.4 days (range 2-6). The average number of days on the ventilator was 15 (range 4-27). There were no major complications due to the procedure. Survival to discharge was 100%. Average follow up is 4.4 years (range 1-15). A short run of VV-ECMO can be lifesaving for pediatric patients in respiratory failure. Survival is excellent despite severely elevated oxygen indices. VV-ECMO may be well tolerated and can be considered for severe pediatric respiratory failure.

UR - http://www.scopus.com/inward/record.url?scp=85020121047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020121047&partnerID=8YFLogxK

M3 - Article

C2 - 27670564

AN - SCOPUS:85020121047

VL - 82

SP - 787

EP - 788

JO - Handbook of Behavioral Neuroscience

JF - Handbook of Behavioral Neuroscience

SN - 0003-1348

IS - 9

ER -